317 related articles for article (PubMed ID: 31729564)
21. Gut Dysbiosis Thwarts the Efficacy of Vaccine Against
Nadeem S; Maurya SK; Das DK; Khan N; Agrewala JN
Front Immunol; 2020; 11():726. PubMed ID: 32508806
[TBL] [Abstract][Full Text] [Related]
22. Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed.
Wipperman MF; Fitzgerald DW; Juste MAJ; Taur Y; Namasivayam S; Sher A; Bean JM; Bucci V; Glickman MS
Sci Rep; 2017 Sep; 7(1):10767. PubMed ID: 28883399
[TBL] [Abstract][Full Text] [Related]
23. Gut bacterial and fungal dysbiosis in tuberculosis patients.
Han M; Wang X; Zhang J; Su L; Ishaq HM; Li D; Cui J; Zhao H; Yang F
BMC Microbiol; 2024 Apr; 24(1):141. PubMed ID: 38658829
[TBL] [Abstract][Full Text] [Related]
24. The Host Microbiota Contributes to Early Protection Against Lung Colonization by
Dumas A; Corral D; Colom A; Levillain F; Peixoto A; Hudrisier D; Poquet Y; Neyrolles O
Front Immunol; 2018; 9():2656. PubMed ID: 30487801
[TBL] [Abstract][Full Text] [Related]
25. The microbiome and tuberculosis: state of the art, potential applications, and defining the clinical research agenda.
Naidoo CC; Nyawo GR; Wu BG; Walzl G; Warren RM; Segal LN; Theron G
Lancet Respir Med; 2019 Oct; 7(10):892-906. PubMed ID: 30910543
[TBL] [Abstract][Full Text] [Related]
26. The Dysbiosis Triggered by First-Line Tuberculosis Antibiotics Fails to Reduce Their Bioavailability.
Namasivayam S; Zimmerman M; Oland S; Wang H; Mittereder LR; Dartois V; Sher A
mBio; 2023 Apr; 14(2):e0035323. PubMed ID: 36877010
[TBL] [Abstract][Full Text] [Related]
27. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.
Woodhouse CA; Patel VC; Singanayagam A; Shawcross DL
Aliment Pharmacol Ther; 2018 Jan; 47(2):192-202. PubMed ID: 29083037
[TBL] [Abstract][Full Text] [Related]
28. Impact of the gut-lung axis on tuberculosis susceptibility and progression.
Enjeti A; Sathkumara HD; Kupz A
Front Microbiol; 2023; 14():1209932. PubMed ID: 37485512
[TBL] [Abstract][Full Text] [Related]
29. Intestinal dysbiosis compromises alveolar macrophage immunity to Mycobacterium tuberculosis.
Khan N; Mendonca L; Dhariwal A; Fontes G; Menzies D; Xia J; Divangahi M; King IL
Mucosal Immunol; 2019 May; 12(3):772-783. PubMed ID: 30783183
[TBL] [Abstract][Full Text] [Related]
30. The Microbiome in Crohn's Disease: Role in Pathogenesis and Role of Microbiome Replacement Therapies.
Khanna S; Raffals LE
Gastroenterol Clin North Am; 2017 Sep; 46(3):481-492. PubMed ID: 28838410
[TBL] [Abstract][Full Text] [Related]
31. Restoration of dysbiotic human gut microbiome for homeostasis.
Dixit K; Chaudhari D; Dhotre D; Shouche Y; Saroj S
Life Sci; 2021 Aug; 278():119622. PubMed ID: 34015282
[TBL] [Abstract][Full Text] [Related]
32. The Human Microbiome in the Fight Against Tuberculosis.
Wood MR; Yu EA; Mehta S
Am J Trop Med Hyg; 2017 Jun; 96(6):1274-1284. PubMed ID: 28719264
[TBL] [Abstract][Full Text] [Related]
33. New Players in Immunity to Tuberculosis: The Host Microbiome, Lung Epithelium, and Innate Immune Cells.
Gupta N; Kumar R; Agrawal B
Front Immunol; 2018; 9():709. PubMed ID: 29692778
[TBL] [Abstract][Full Text] [Related]
34. The gut microbiome: A line of defense against tuberculosis development.
Yu Z; Shen X; Wang A; Hu C; Chen J
Front Cell Infect Microbiol; 2023; 13():1149679. PubMed ID: 37143744
[TBL] [Abstract][Full Text] [Related]
35. Microbiome Changes during Tuberculosis and Antituberculous Therapy.
Hong BY; Maulén NP; Adami AJ; Granados H; Balcells ME; Cervantes J
Clin Microbiol Rev; 2016 Oct; 29(4):915-26. PubMed ID: 27608937
[TBL] [Abstract][Full Text] [Related]
36. Multiple sclerosis and faecal microbiome transplantation: are you going to eat that?
Wing AC; Kremenchutzky M
Benef Microbes; 2019 Feb; 10(1):27-32. PubMed ID: 30525949
[TBL] [Abstract][Full Text] [Related]
37. Obesity-Induced Dysbiosis Exacerbates IFN-γ Production and Pulmonary Inflammation in the
Palma Albornoz SP; Fraga-Silva TFC; Gembre AF; de Oliveira RS; de Souza FM; Rodrigues TS; Kettelhut IDC; Manca CS; Jordao AA; Ramalho LNZ; Ribolla PEM; Carlos D; Bonato VLD
Cells; 2021 Jul; 10(7):. PubMed ID: 34359902
[TBL] [Abstract][Full Text] [Related]
38. Hidden Role of Gut Microbiome Dysbiosis in Schizophrenia: Antipsychotics or Psychobiotics as Therapeutics?
Munawar N; Ahsan K; Muhammad K; Ahmad A; Anwar MA; Shah I; Al Ameri AK; Al Mughairbi F
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299291
[TBL] [Abstract][Full Text] [Related]
39.
Petruccioli E; Petrone L; Chiacchio T; Farroni C; Cuzzi G; Navarra A; Vanini V; Massafra U; Lo Pizzo M; Guggino G; Caccamo N; Cantini F; Palmieri F; Goletti D
Front Immunol; 2021; 12():716857. PubMed ID: 34447382
[TBL] [Abstract][Full Text] [Related]
40. The Gut Microbiome Signatures Discriminate Healthy From Pulmonary Tuberculosis Patients.
Hu Y; Feng Y; Wu J; Liu F; Zhang Z; Hao Y; Liang S; Li B; Li J; Lv N; Xu Y; Zhu B; Sun Z
Front Cell Infect Microbiol; 2019; 9():90. PubMed ID: 31001490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
